Ignite Creation Date:
2024-05-05 @ 9:27 PM
Last Modification Date:
2024-10-26 @ 10:04 AM
Study NCT ID:
NCT00884949
Status:
COMPLETED
Last Update Posted:
2014-06-30
First Post:
2009-04-10
Brief Title:
A Study to Evaluate the Safety Tolerability and Efficacy of BMN 110 in Subjects With Mucopolysaccharidosis IVA
Sponsor:
BioMarin Pharmaceutical
Organization:
BioMarin Pharmaceutical
Conditions & Keywords Data
Conditions:
| Name |
|---|
| MPS IV A |
Keywords:
| Name | View |
|---|---|
| ERT | View |
| Mucopolysaccharidosis IV type A | View |
| MPS IV Type A | View |
| Mucopolysaccharidosis IVA | View |
| MPS IVA | View |
| Morquio A Syndrome | View |
| Lysosomal Storage Disorder | View |
| LSD | View |
| N-acetylgalactosamine-6-sulfatase | View |
| N-acetylgalactosamine-6-sulfate sulfatase | View |
| galactose-6-sulfatase | View |
| GALNS | View |
| enzyme replacement therapy | View |